Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

592 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402).
Piulats JM, Espinosa E, de la Cruz Merino L, Varela M, Alonso Carrión L, Martín-Algarra S, López Castro R, Curiel T, Rodríguez-Abreu D, Redrado M, Gomà M, Rullán AJ, Calvo González A, Berrocal-Jaime A. Piulats JM, et al. Among authors: espinosa e. J Clin Oncol. 2021 Feb 20;39(6):586-598. doi: 10.1200/JCO.20.00550. Epub 2021 Jan 8. J Clin Oncol. 2021. PMID: 33417511 Clinical Trial.
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative Group.
González Barón M, Feliu J, Espinosa E, García Girón C, Blanco E, Garrido P, Colmenarejo A, Ordóñez A, Moyano A, de la Gándara I, et al. González Barón M, et al. Among authors: espinosa e. Ann Oncol. 1994 Apr;5(4):323-7. doi: 10.1093/oxfordjournals.annonc.a058834. Ann Oncol. 1994. PMID: 8075028 Free article. Clinical Trial.
Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen.
Feliu J, González Barón M, Chacón JI, Espinosa E, Garrido P, Castro J, Escobar Y, Colmenarejo A, Jara C, García Girón C, Espinosa J, Ordóñez A. Feliu J, et al. Among authors: espinosa j, espinosa e. Cancer Chemother Pharmacol. 1996;38(2):191-4. doi: 10.1007/s002800050469. Cancer Chemother Pharmacol. 1996. PMID: 8616911 Clinical Trial.
Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. ONCOPAZ Cooperative Group, Spain.
Feliu J, González Barón M, García Girón C, Espinosa E, Vicent JM, Gómez Navarro J, Berrocal A, Ordóñez A, Vilches Y, de Castro J, Díaz J. Feliu J, et al. Among authors: espinosa e. Am J Clin Oncol. 1996 Dec;19(6):577-80. doi: 10.1097/00000421-199612000-00009. Am J Clin Oncol. 1996. PMID: 8931675 Clinical Trial.
UFT modulated with leucovorin in advanced colorectal cancer: Oncopaz experience.
González Barón M, Feliu J, Garcia Girón C, Espinosa J, Martinez B, Blanco E, Crespo MC, Ordóñez A, Espinosa E, de Castro J, Juárez F, Colmenarejo A. González Barón M, et al. Among authors: espinosa j, espinosa e. Oncology. 1997;54 Suppl 1:24-9. doi: 10.1159/000227742. Oncology. 1997. PMID: 8978581 Clinical Trial.
Renal tolerance to cisplatin in patients 70 years and older.
Cubillo A, Cornide M, López JL, Molina R, Feliu J, Espinosa E, Zamora P, de Castro J, Ordoñez A, González Barón M. Cubillo A, et al. Among authors: espinosa e. Am J Clin Oncol. 2001 Apr;24(2):192-7. doi: 10.1097/00000421-200104000-00018. Am J Clin Oncol. 2001. PMID: 11319297
Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy.
Feliu J, Calvilio J, Escribano A, de Castro J, Sánchez ME, Mata A, Espinosa E, García Grande A, Mateo A, González Barón M. Feliu J, et al. Among authors: espinosa e. Ann Oncol. 2002 May;13(5):730-6. doi: 10.1093/annonc/mdf116. Ann Oncol. 2002. PMID: 12075741 Free article. Clinical Trial.
592 results